BACKGROUND: small-bowel cancer is uncommon and, accordingly, little is known about the epidemiology of this malignancy, especially by race and subtype.
s mall-bowel malignancies are rare, accounting for less than half a percent of all malignancies and 1% to 2% of Gi neoplasms. 1 accordingly, little is known about the epidemiology.
2,3 the infrequency of these tumors is perplexing because the small intestine, which is made up of the duodenum, jejunum, and ileum, includes 90% of the mucosal surface area of the digestive tract; and cell turnover in this organ is rapid, enhancing susceptibility to carcinogens, especially from the bile and diet. [4] [5] [6] furthermore, the incidence of malignancy in adjacent digestive organs, the stomach and colon, is comparatively high. 7 symptoms of small-bowel cancer are nonspecific, and diagnosis is difficult. 8 this, combined with the aggressiveness of the tumor, renders the 5-year relative survival probability poor in the united states at 59%. for this malignancy. 10 Rates are high in north america, northern europe, and oceania, and lower in eastern europe, the middle east, and various asian, african, and latin American countries, with the exception of Brazil. Men have higher rates of small-bowel cancer in comparison with women in most countries. Blacks in the United States have among the highest rates of small-bowel cancer in the world, although the reason for this is unclear.
analytic studies of small-bowel cancer have been small, with fewer than 100 cases, in general, and inconclusive. Risk factors for small-bowel cancer include autoimmune diseases, such as Crohn's disease, ulcerative colitis, and celiac disease, familial adenomatous polyposis and Peutz-Jeghers syndrome, consumption of red meat, obesity, and various occupations. 2, 3, [5] [6] [7] [8] Reports of an association of tobacco smoking and alcohol consumption with the risk of developing small-bowel cancer are inconsistent. 2, 3 in this analysis, we describe demographic and clinical features of small-bowel cancer in the united states by using information from cancer registries representing 66% of the population. an important objective was to monitor the reported increase in small-bowel cancer, especially Gi stromal tumor (Gist) and carcinoid tumors, in a representative population-based study.
METHODS

Sources of Data
Cancer registries in the united states that participate in the national Cancer institute's surveillance, epidemiology, and end Results program or the CDC's national Program of Cancer Registries contribute data annually to the north american association of Central Cancer Registries (naaCCR). Data from each contributing registry are required to pass rigid quality criteria for completeness of reporting, nonduplication of records, internal consistency among data items, and low percentage of death certificate only cases. 11 naaCCR provided 2 data sets that were used in this analysis. the first file, Cancer incidence in north america Deluxe, was used in the analysis of race (white, black, american indian-alaska native, asian-Pacific islander). 11 the second file, Cancer in us hispanics/latinos, was used in the analysis of hispanic ethnicity irrespective of race. 12 only registries with data available for all 14 years from 1995 to 2008 were included in this analysis.
Qualifying states that participated through written consent represented 66% of the us population, including 65% of the white population, 55% of the black population, 83% of the asian-Pacific islander population, 62% of the alaska native-american indian population, and 88% of the us hispanic population. although there were too few american indian-alaska native cases (77 men and 48 women) to do some of the subgroup analyses, they were included as part of the total. Statistical Analysis initially, we created frequency distributions to characterize cases by the variables of interest including age, race, hispanic ethnicity, and histology. frequencies were compared between racial and ethnic groups by age and histology. age-adjusted incidence rates were expressed per million population. all rates were age adjusted by 5-year age groups to compare racial and ethnic groups by demographic, pathological, and clinical variables of interest. 14 Confidence intervals for the rates were calculated by the method of fay and feuer, 15 which is an exact method based on the gamma distribution and is particularly well suited when cell counts are small. the 2000 us population was used for age standardization. For all analyses, rates were suppressed when the category had fewer than 20 cases.
incidence rate ratios, 95% Ci, and significance tests for the incidence rate ratios were calculated to assess patterns in cancer incidence. 16, 17 we examined differences in the log age-specific incidence rates separately by race and hispanic ethnicity by the use of the Poisson model. the annual percentage change in rates between 1995 and 2008 was calculated to assess a trend in incidence rates. the statistical comparison of trends was based on the t test of the trend regression parameter. all analyses were conducted with the use of sas version 9.2.
RESULTS
Age-Adjusted Incidence Rates by Sex a total of 30,569 men and 25,823 women were diagnosed with small-bowel cancer between 1995 and 2008 (table 1) . women experienced 32% lower rates of small-bowel cancer than men (age-adjusted incidence rate = 17.7 per million for women and 26.1 per million for men), with the biggest male-to-female relative rate differences for lymphomas, especially the Burkitt lymphoma, and the smallest male-to-female differences for other specified carcinomas, hormone-specific carcinoid tumors, smallcell neuroendocrine carcinoma, and follicular B-cell lymphoma. neuroendocrine tumors were the most common histological types of small-bowel cancer in men and women, followed by carcinoma, lymphoma, and sarcoma (ie, Gists).
Age-Adjusted Incidence
Rates by Race the rate of small-bowel cancer was 42% greater among black men than among white men, and 46% greater among black women than among white women (table 2) . By contrast, the rate of small-bowel cancer was 34% lower among asian-Pacific islander men than among white men, and 37% lower among asian-Pacific islander women than among white women. a large part of the excess of smallbowel cancer among blacks in comparison with whites was attributable to the incidence of adenocarcinoma and carcinoid tumors. By contrast, rates for adenocarcinoma and carcinoid tumors were significantly lower among asian-Pacific islanders in comparison with white men and women. the incidence of Gist was significantly more common among asian-Pacific islander men and women than the incidence among white men and women. leiomyosarcoma was significantly less common among black women than among white women, but not significantly reduced among black men. the rates for B-cell lymphoma overall, particularly diffuse large B-cell Rates are per 1,000,000 and age adjusted to the 2000 US standard population. Counts <20 are suppressed. NOS = not otherwise specified; NK = natural killer; AAIR = age-adjusted incidence rate; IRR, incidence rate ratio.
lymphoma, follicular and marginal zone (women only) types were significantly lower among blacks than whites, whereas the rates for follicular large B-cell lymphoma were significantly lower among asian-Pacific islanders than whites of both sexes, and marginal zone large B-cell lymphoma and t-cell lymphoma were significantly higher among asian-Pacific islander men than among white men.
Age-Adjusted Incidence Rates by Hispanic Ethnicity
the rate of small-bowel cancer was 24% lower among hispanic men than among non-hispanic men (table 3) . Rates among hispanic men also tended to be lower for most histological types. in contrast, although the rate of small-bowel cancer was 15% lower among hispanic women than among non-hispanic women, this was largely Incidence rates are per 1,000,000 and age adjusted to the 2000 US standard population. Counts <20 are suppressed. NOS = not otherwise specified; AAIR = age-adjusted incidence rate; IRR = incidence rate ratio. Incidence rates are per 1,000,000 and age adjusted to the 2000 US standard population. Counts <20 are suppressed. NOS = not otherwise specified; AAIR = age-adjusted incidence rate; IRR = incidence rate ratio.
driven by relative rate differences for carcinoid tumors.
Rates were similar between hispanic and non-hispanic women for most histological types. Relative rate differences between hispanics and non-hispanics were greatest for carcinoid tumors and follicular large B-cell lymphoma for both sexes.
Trends by Race or Hispanic Ethnicity
During the 14-year period from 1995 to 2008, the rate of small-bowel cancer in the united states increased at a statistically significant annual rate for white (2.1%) and black (1.9%) men but not for asian-Pacific islander (0.4%) men ( fig. 1a) . similarly, rates increased at a statistically significant annual rate for white (2.6%) and black (3.1%) women but not for asian-Pacific islander (0.2%) women (Fig. 1B) . The rate of small-bowel cancer increased at a statistically significant annual rate for non-hispanic (2.2%) men but not for hispanic (0.8%) men ( fig. 1C ). however, rates increased at a statistically significant annual rate for both non-hispanic (2.7%) and hispanic (2.4%) women ( fig. 1D ).
Age-Specific Rates by Race or Hispanic Ethnicity
age-specific rates for small-bowel cancer were generally higher among men than among women in all racial and ethnic groups ( Figs. 2A and B) . Rates for small-bowel cancer among asian-Pacific islanders generally exceeded those for whites and blacks from 5 to 9 years to 25 to 29 years at diagnosis. Blacks experienced the highest rates of smallbowel cancer after age 25 to 29 years at diagnosis. age-specific rates for duodenal cancer were similar for whites and asian-Pacific islanders, but much higher for all adult blacks (data not shown). By contrast, age-specific rates for cancer of the ileum were similar between blacks and whites, but much lower among asian-Pacific islanders. Race-specific rates for cancer of the jejunum were less distinct, but generally higher among blacks (data not shown). non-hispanic men and women generally had higher rates of small-bowel cancer than did hispanics, although the age-specific differences were more pronounced for men than for women (figs. 2C and D). Rates for duodenum cancer, but not jejunum or ileum cancers, were similar between hispanics and non-hispanics at all age groups, but rates among hispanic women exceeded the rates among non-hispanic women after the age of 54 years (data not shown).
Trends by Histology
During the 14-year period from 1995 to 2008, the rate of small-bowel cancer in the united states increased at a significant annual rate of 2.1% among men and 2.6% among women ( fig. 3) . the annual percentage of change in rates was greatest for Gist at 11.3% in men and 11.3% in women. After GIST, follicular B-cell lymphoma increased at a significant annual rate of 4.7% in men and 4.7% in women, neuroendocrine tumors increased at a significant annual rate of 4.9% in men and 5.3% in women, and sarcomas increased at a significant annual rate of 2.1% in men and (not significant) 1.8% in women.
the annual percentage of decrease in rates was greatest for leiomyosarcoma at −18.3% annually in men and −20.0% annually in women (data not shown). significant declines in the rates of unspecified cancer were observed in both sexes.
DISCUSSION
our analysis of us cancer registry data showed substantial racial and ethnic variation in the incidence of histological subtypes of small-bowel malignancy, suggesting diverse cellular origins. although the rates of small-bowel cancer among asian-Pacific islanders were generally lower than rates among whites, Gist was a notable exception. the significantly higher incidence of Gist among asian-Pacific islanders suggests a greater genetic susceptibility to Gist; however, mutations in tyrosine kinase c-kit (CD117) receptor activity, which is present in 85% of Gists, appear to be associated with proliferation of Gist rather than carcinogenesis or malignant transformation. 18 therefore, it is possible that nongenetic factors may be contributing to higher rates of Gist observed in asian-Pacific islanders. the us rates of Gist increased for both men (11.3%) and women (11.3%) during the 1995 to 2008 observation period, whereas the rates of leiomyosarcoma decreased for men (18.3%) and women (20.0%), likely a result of improved pathological differentiation between leiomyosarcomas and Gist. 19 in the past, Gists were commonly misclassified as leiomyosarcomas, but these 2 sarcomas can now be distinguished by the use of immunohistochemistry.
adenocarcinoma was the most common histological type of small-bowel cancer in the united states during the 1970s and 1980s. 20 however, by the 1990s, the incidence of carcinoid tumors, neuroendocrine cancers that accounted for 36% of tumors in the small bowel, surpassed that of adenocarcinoma. 21, 22 Carcinoids are heterogeneous gastroenteropancreatic tumors occurring most commonly in the ileum, which is lined with neuroendocrine system cells that secrete various digestive hormones into the blood. 23 the most dramatic increase in the rates of carcinoid tumors was among blacks followed by whites. in contrast to blacks and whites, the incidence of adenocarcinoma in asian-Pacific islanders and hispanics was higher than the incidence of neuroendocrine tumors. Rates of carcinoid tumors were particularly low among hispanics in comparison with non-hispanics, implying differences in disease epidemiology between these groups. incidence-based mortality rate patterns were similar to incidence rate patterns (data not shown); therefore, we did not include them in the current study.
our study is not without limitations. first, our analysis was restricted to registries with data for the entire 14-year study period. in a sensitivity analysis, incidence rates by race were similar for excluded and included registries, but tended to be lower for hispanics in the excluded registries in comparison with hispanics in the included registries (data not shown). however, because rates for hispanics in the excluded registries were lower than those in the included registries, the true difference in the incidence rates between non-hispanics and hispanics is likely to be greater than what we observed in the current study. second, our study was descriptive in nature and therefore did not provide definitive information regarding the origin small-bowel cancer. finally, information on histological subtype was not determined in a centralized or standardized manner, and it was therefore subject to differences in diagnostic practices across the united states, and changes in criteria over time, as well. Despite these limitations, to our knowledge, this is one of the largest studies of small-bowel cancer to date; our data represented high-quality population-based data covering 66% of the total us population, whereas prior studies have represented less than 14% of the total us population. furthermore, our study considered potential differences in age-adjusted incidence rate trends and age-specific rates by race/ethnicity and sex, as well as histology and sex, rather than each factor (race/ethnicity, histology, sex) alone.
the incidence of small-bowel malignancy has continued to increase at an alarming pace in the united states, although the cause is unknown and unlikely to be a result of improved detection because the symptoms are vague. of special concern is the high rate of small-bowel cancer in black men and women, particularly rates of adenocarcinoma and carcinoid tumors. the relative rates of smallbowel cancer in asian-Pacific islanders and hispanics in comparison with whites and blacks were inconsistent across histological subtypes, underscoring the substantial etiologic heterogeneity of this malignancy. this heterogeneity poses a considerable challenge to future epide- 
